News
Capricor Therapeutics (NASDAQ:CAPR) lost ~15% on Friday after the cell therapy developer posted long-term data from an ...
General Mills offers a safe, attractive dividend and stability, but faces headwinds from declining sales and shifting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback